| Dr John Andrew Washburn, | |
|
1307 Porter Wagoner Blvd, West Plains, MO 65775-1828 | |
| (417) 255-8645 | |
| (417) 255-8649 |
| Full Name | Dr John Andrew Washburn |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 15 Years |
| Location | 1307 Porter Wagoner Blvd, West Plains, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578792644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2012020883 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kindred At Home | Rolla, MO | Home health agency |
| Ozarks Medical Center | West plains, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ozarks Medical Center | 3870491863 | 142 |
News Archive
The Wall Street Journal reports: "Anti-abortion groups are gearing up for a battle in the fall over health-care legislation, another headache for Democrats who already face concerns about the measure's cost and reach. Most versions of the Democratic health plan would create subsidies for lower-income people to buy private health insurance.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
A new infection alert system in catheters could prevent serious infections in millions of hospital patients worldwide. The system, detailed in a new paper in Biosensors and Bioelectronics, changes the color of the urine so patients and carers can see easily if bacteria are starting to block the catheter.
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
› Verified 4 days ago
| Entity Name | Ozarks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831115641 PECOS PAC ID: 3870491863 Enrollment ID: O20040209001035 |
News Archive
The Wall Street Journal reports: "Anti-abortion groups are gearing up for a battle in the fall over health-care legislation, another headache for Democrats who already face concerns about the measure's cost and reach. Most versions of the Democratic health plan would create subsidies for lower-income people to buy private health insurance.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
A new infection alert system in catheters could prevent serious infections in millions of hospital patients worldwide. The system, detailed in a new paper in Biosensors and Bioelectronics, changes the color of the urine so patients and carers can see easily if bacteria are starting to block the catheter.
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
› Verified 4 days ago
| Entity Name | Ozarks Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831115641 PECOS PAC ID: 3870491863 Enrollment ID: O20040211000422 |
News Archive
The Wall Street Journal reports: "Anti-abortion groups are gearing up for a battle in the fall over health-care legislation, another headache for Democrats who already face concerns about the measure's cost and reach. Most versions of the Democratic health plan would create subsidies for lower-income people to buy private health insurance.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
A new infection alert system in catheters could prevent serious infections in millions of hospital patients worldwide. The system, detailed in a new paper in Biosensors and Bioelectronics, changes the color of the urine so patients and carers can see easily if bacteria are starting to block the catheter.
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
› Verified 4 days ago
| Entity Name | Lester E Cox Medical Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538334396 PECOS PAC ID: 1254248917 Enrollment ID: O20050624000293 |
News Archive
The Wall Street Journal reports: "Anti-abortion groups are gearing up for a battle in the fall over health-care legislation, another headache for Democrats who already face concerns about the measure's cost and reach. Most versions of the Democratic health plan would create subsidies for lower-income people to buy private health insurance.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
A new infection alert system in catheters could prevent serious infections in millions of hospital patients worldwide. The system, detailed in a new paper in Biosensors and Bioelectronics, changes the color of the urine so patients and carers can see easily if bacteria are starting to block the catheter.
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
› Verified 4 days ago
| Entity Name | Through Him Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033508254 PECOS PAC ID: 4688999808 Enrollment ID: O20150211000529 |
News Archive
The Wall Street Journal reports: "Anti-abortion groups are gearing up for a battle in the fall over health-care legislation, another headache for Democrats who already face concerns about the measure's cost and reach. Most versions of the Democratic health plan would create subsidies for lower-income people to buy private health insurance.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
A new infection alert system in catheters could prevent serious infections in millions of hospital patients worldwide. The system, detailed in a new paper in Biosensors and Bioelectronics, changes the color of the urine so patients and carers can see easily if bacteria are starting to block the catheter.
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Andrew Washburn, 1307 Porter Wagoner Blvd, West Plains, MO 65775-1828 Ph: (417) 255-8645 | Dr John Andrew Washburn, 1307 Porter Wagoner Blvd, West Plains, MO 65775-1828 Ph: (417) 255-8645 |
News Archive
The Wall Street Journal reports: "Anti-abortion groups are gearing up for a battle in the fall over health-care legislation, another headache for Democrats who already face concerns about the measure's cost and reach. Most versions of the Democratic health plan would create subsidies for lower-income people to buy private health insurance.
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD.
A new infection alert system in catheters could prevent serious infections in millions of hospital patients worldwide. The system, detailed in a new paper in Biosensors and Bioelectronics, changes the color of the urine so patients and carers can see easily if bacteria are starting to block the catheter.
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
› Verified 4 days ago
Dr. Leslie Erin Barr, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 805 N Kentucky Ave, West Plains, MO 65775 Phone: 417-256-2111 Fax: 417-256-4858 | |
Shannon Nicole Marsden, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1307 Porter Wagoner Blvd, West Plains, MO 65775 Phone: 417-255-8645 | |
Dr. Thomas Henry Benton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1801 E State Route K, West Plains, MO 65775 Phone: 417-257-2454 | |
Druery J Dixon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 181 N Kentucky Ave, Suite 100, West Plains, MO 65775 Phone: 417-257-5911 Fax: 417-257-5913 | |
Aaron Lee Mills, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 805 N Kentucky Ave, West Plains, MO 65775 Phone: 417-256-2111 Fax: 417-256-4858 | |
Dr. Douglas A Crase, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 805 N Kentucky Ave, West Plains, MO 65775 Phone: 417-256-2111 | |
Curtis L Horstman, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 805 N Kentucky Ave, West Plains, MO 65775 Phone: 417-256-2111 Fax: 417-256-4858 |